LA
Laurus Labs
LAURUSLABS.NS·NSEHyderabad INFounded 20058,000 employees
Mid CappharmaPublicInfectious DiseaseOncology
Platform: API & CDMO
Market Cap
$3B
All Drugs
3
Clinical Trials
4
Failed / Terminated
2
FDA Approved
0
Stock Price & Catalysts (LAURUSLABS.NS)
Loading LAURUSLABS.NS stock data...
Drug Pipeline (3 programs)
| Drug Name | Code | Phase | Trials | Modality | Target | MOA | Indications |
|---|---|---|---|---|---|---|---|
| LAU-4167 | LAU-4167 | NDA/BLA | 2 | AHR | SCDFSGS | ||
| LAU-2489 | LAU-2489 | Phase 2 | 1 | B7-H3 | HSMS | ||
| Cevinaritide | LAU-8989 | Preclinical | 1 | BTK | MDS |
SEC Filings & Financial Documents
SEC filings are not available for NSE-listed companies.
Laurus Labs trades on NSE (IN). SEC EDGAR only covers US-listed issuers.
Insider Trading Activity
Insider trading data is not available for non-US exchanges.
Catalyst Events (4)